These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17450152)

  • 1. The structure of a polyQ-anti-polyQ complex reveals binding according to a linear lattice model.
    Li P; Huey-Tubman KE; Gao T; Li X; West AP; Bennett MJ; Bjorkman PJ
    Nat Struct Mol Biol; 2007 May; 14(5):381-7. PubMed ID: 17450152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear and extended: a common polyglutamine conformation recognized by the three antibodies MW1, 1C2 and 3B5H10.
    Klein FA; Zeder-Lutz G; Cousido-Siah A; Mitschler A; Katz A; Eberling P; Mandel JL; Podjarny A; Trottier Y
    Hum Mol Genet; 2013 Oct; 22(20):4215-23. PubMed ID: 23777629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-PolyQ Antibodies Recognize a Short PolyQ Stretch in Both Normal and Mutant Huntingtin Exon 1.
    Owens GE; New DM; West AP; Bjorkman PJ
    J Mol Biol; 2015 Jul; 427(15):2507-2519. PubMed ID: 26047735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
    Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
    J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
    Popiel HA; Nagai Y; Onodera O; Inui T; Fujikake N; Urade Y; Strittmatter WJ; Burke JR; Ichikawa A; Toda T
    Biochem Biophys Res Commun; 2004 May; 317(4):1200-6. PubMed ID: 15094397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A toxic monomeric conformer of the polyglutamine protein.
    Nagai Y; Inui T; Popiel HA; Fujikake N; Hasegawa K; Urade Y; Goto Y; Naiki H; Toda T
    Nat Struct Mol Biol; 2007 Apr; 14(4):332-40. PubMed ID: 17369839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch.
    Okamoto Y; Nagai Y; Fujikake N; Akiko Popiel H; Yoshioka T; Toda T; Inui T
    Biochem Biophys Res Commun; 2009 Jan; 378(3):634-9. PubMed ID: 19061859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal toxicity of expanded polyglutamine depends on intracellular distribution in addition to the expression level.
    Satoh M; Shimada A; Kawamura N; Chiba Y; Yoshikawa K; Ishii S; Furukawa A; Kumagai N; Hosokawa M
    Neuropathology; 2008 Oct; 28(5):485-96. PubMed ID: 18384512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A linear lattice model for polyglutamine in CAG-expansion diseases.
    Bennett MJ; Huey-Tubman KE; Herr AB; West AP; Ross SA; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11634-9. PubMed ID: 12193654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyglutamine homopolymers having 8-45 residues form slablike beta-crystallite assemblies.
    Sharma D; Shinchuk LM; Inouye H; Wetzel R; Kirschner DA
    Proteins; 2005 Nov; 61(2):398-411. PubMed ID: 16114051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structural impact of a polyglutamine tract is location-dependent.
    Robertson AL; Horne J; Ellisdon AM; Thomas B; Scanlon MJ; Bottomley SP
    Biophys J; 2008 Dec; 95(12):5922-30. PubMed ID: 18849414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folding of polyglutamine chains.
    Chopra M; Reddy AS; Abbott NL; de Pablo JJ
    J Chem Phys; 2008 Oct; 129(13):135102. PubMed ID: 19045125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function.
    Schiffer NW; Céraline J; Hartl FU; Broadley SA
    Biol Chem; 2008 Dec; 389(12):1455-66. PubMed ID: 18844449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyglutamine repeats and beta-helix structure: molecular dynamics study.
    Merlino A; Esposito L; Vitagliano L
    Proteins; 2006 Jun; 63(4):918-27. PubMed ID: 16514608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM; Bottomley SP
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration.
    Wong SL; Chan WM; Chan HY
    FASEB J; 2008 Sep; 22(9):3348-57. PubMed ID: 18559990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure and thermodynamic analysis of diagnostic mAb 106.3 complexed with BNP 5-13 (C10A).
    Longenecker KL; Ruan Q; Fry EH; Saldana SC; Brophy SE; Richardson PL; Tetin SY
    Proteins; 2009 Aug; 76(3):536-47. PubMed ID: 19274732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rate of polyQ-mediated aggregation is dramatically affected by the number and location of surrounding domains.
    Robertson AL; Bate MA; Buckle AM; Bottomley SP
    J Mol Biol; 2011 Nov; 413(4):879-87. PubMed ID: 21945530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous formation of annular structures observed in molecular dynamics simulations of polyglutamine peptides.
    Marchut AJ; Hall CK
    Comput Biol Chem; 2006 Jun; 30(3):215-8. PubMed ID: 16678490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of an anti-cholera toxin antibody Fab in complex with an epitope-derived D-peptide: a case of polyspecific recognition.
    Scheerer P; Kramer A; Otte L; Seifert M; Wessner H; Scholz C; Krauss N; Schneider-Mergener J; Höhne W
    J Mol Recognit; 2007; 20(4):263-74. PubMed ID: 17712773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.